I thought the deal Pharmaxis did today was interesting...http://www.copyright link/business/...50m-beohringer-ingelheim-deal-20150518-gh45b1
$39m up-front based on interim data that has not yet gone through clinical trials. Doesn't sound too far away from where PYC want to be by year-end, i.e. getting into the clinic with a few internal projects.
Might solve a few cash flow concerns if they could pull something like that through..
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.21 |
Change
-0.030(2.42%) |
Mkt cap ! $705.7M | |||
| Open | High | Low | Value | Volume |
| $1.24 | $1.26 | $1.21 | $627.7K | 506.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 4985 | $1.21 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.26 | 4115 | 1 |
View Market Depth
| Last trade - 16.10pm 01/08/2025 (20 minute delay) ? |
| PYC (ASX) Chart |